topoisomerase I inhibitors (Rutgers/Genzyme)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Nametopoisomerase I inhibitors (Rutgers/Genzyme)
Drug Alias NametopovaleARC-111ARC-31
ClassificationSmall molecules
Mechanisms of ActionDNA topoisomerase I inhibitorsHypoxia-inducible factor 1 alpha inhibitors
TargetsDNA topoisomerase IHypoxia-inducible factor 1 alpha
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRutgers University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGenzyme CorpRutgers University
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A